The future of malaria control in light of RTS,S
Priya Venkatesan
Abstract
The first antiparasitic RTS,S/AS01 (RTS,S) malaria vaccine, recommended by WHO in 2021 to be given to children living in regions with moderate-to-high transmission of Plasmodium falciparum malaria, is a huge step forward in the fight against malaria. However, many challenges remain for eliminating the disease. One such challenge is that the RTS,S vaccine is not expected to protect against the other human malaria parasites, namely Plasmodium vivax, Plasmodium ovale, Plasmodium malariae, and the zoonotic Plasmodium knowlesi.
Topics & Concepts
MalariaPlasmodium malariaePlasmodium knowlesiPlasmodium ovalePlasmodium falciparumPlasmodium vivaxMalaria vaccineVirologyPlasmodium (life cycle)BiologyTransmission (telecommunications)MedicineImmunologyParasite hostingElectrical engineeringWorld Wide WebEngineeringComputer scienceMalaria Research and Control